Athira Pharma Inc ATHA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/14/24 EDT
2.20quote price arrow down-0.11 (-4.76%)
Volume
90,630
52 week range
1.33 - 4.30
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.20
  • 52 Week High4.30
  • 52 Week High Date02/21/24
  • 52 Week Low1.33
  • 52 Week Low Date11/09/23

Key Stats

  • Market Cap84.319M
  • Shares Out38.33M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta2.87
  • YTD % Change-9.47

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.20
  • 52 Week High4.30
  • 52 Week High Date02/21/24
  • 52 Week Low1.33
  • 52 Week Low Date11/09/23
  • Market Cap84.319M
  • Shares Out38.33M
  • 10 Day Average Volume0.15M
  • Dividend-
  • Dividend Yield-
  • Beta2.87
  • YTD % Change-9.47

RATIOS/PROFITABILITY

  • EPS (TTM)-3.10
  • P/E (TTM)-0.71
  • Fwd P/E (NTM)-0.73
  • EBITDA (TTM)-126.125M
  • ROE (TTM)-64.42%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Athira Pharma Inc

 

Content From Our Affiliates

Profile

MORE
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company. It focuses on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline consists of both blood brain barrier permeable and peripherally restricted drug candidates for the central nervous system (CNS), peripheral nervous system, and other indications. Its lead candidate, fosgonimeton (ATH-1017), is a subcutaneously administered, small molecule positive...
Kelly Romano
Independent Chairwoman of the Board
Mark Litton Ph.D.
President, Chief Executive Officer, Director
Rachel Lenington
Chief Operating Officer, Chief Development Officer
Andrew Gengos
Chief Financial Officer and Chief Business Officer
Mark Worthington
General Counsel, Corporate Secretary
Address
18706 North Creek Parkway
Suite 104, Box 352141
Bothell, WA
98011
United States

Top Peers

SYMBOLLASTCHG%CHG
ALRN
Aileron Therapeutics Inc
3.90+0.02+0.52%
SLS
Sellas Life Sciences Group Inc
1.37UNCHUNCH
ANEB
Anebulo Pharmaceuticals Inc
2.28-0.13-5.39%
CGTX
Cognition Therapeutics Inc
1.98+0.03+1.54%
CVM
CEL-SCI Corp
1.39-0.03-2.11%